Codexis Acquires Biocatalytics

ID
114594

DATE

2007-07-19

target

Biocatalytics, Inc.

Pasadena, California
United States
Biocatalytics, Inc. is a private company that has produced custom and off-the-shelf enzymes used in chemical process manufacturing by pharmaceutical and fine chemical companies.
(Show More)

Search 117,219 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Get Started

Acquirer 1

Acquirer DESCRIPTION

Codexis, Inc.

COMPANY
Redwood City, California
United States
www.codexis.com

Life Science

91

42M USD (2015)

Codexis, Inc.

Codexis, Inc. is a developer of biocatalysts. A biocatalyst is an enzyme or microbe that initiates and accelerates a chemical reaction. Company technologies bring improved manufacturing approaches to sectors ranging from the pharmaceutical industry, fine chemicals, flavors and fragrances, to animal health, food and nutrition, agrochemicals and carbon capture.


DEAL STATS #
Acquisition 2 of 2
Sector (Chemicals) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (California) 1 of 1
Country (United States) 1 of 1
Year (2007) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-22 Julich Fine Chemicals GmbH Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-17 Codexis Laboratories Hungary Kft. Sell -